Funds holding “BIOMARIN PHARMACEUTICAL”
Which closed-end funds own a security? Searches the latest N-PORT snapshot of every active fund. Enter a ticker (issuer-level: matches the vendor-mapped ticker), a CUSIP or ISIN (security-level: one specific bond or share class), or part of a name.
38 positions across 35 funds, 4 distinct securities (bonds, share classes and derivatives of the same issuer are listed separately). Weights are percent of net assets from each fund’s latest N-PORT; report dates differ by fund.
| Fund | Position | Identifier | Type | Weight | Value (USD) | Report date | Coverage |
|---|---|---|---|---|---|---|---|
| BME BlackRock Health Sciences Trust Healthcare | BioMarin Pharmaceutical Inc | 09061G101 | EC | 0.30% | $1.7M | Jun 30, 2026 | full (152 positions) |
| BSL Blackstone Senior Floating Rate 2027 Term Fund Senior Loans | Biomarin Pharmaceutical | — | LON | 0.24% | $623K | Jun 30, 2026 | full (401 positions) |
| BGX Blackstone Long-Short Credit Income Fund Taxable Bonds | Biomarin Pharmaceutical | — | LON | 0.23% | $547K | Jun 30, 2026 | full (673 positions) |
| BGB Blackstone Strategic Credit 2027 Term Fund Multi-Asset | Biomarin Pharmaceutical | — | LON | 0.23% | $2M | Jun 30, 2026 | full (671 positions) |
| JQC Nuveen Credit Strategies Income Fund Taxable Bonds | BioMarin Pharmaceutical Inc | 09075UAD6 | LON | 0.22% | $2.6M | Jul 31, 2026 | full (494 positions) |
| JFR Nuveen Floating Rate Income Fund Senior Loans | BioMarin Pharmaceutical Inc | 09075UAD6 | LON | 0.21% | $4.6M | Jul 31, 2026 | full (473 positions) |
| IGI Western Asset Investment Grade Opportunity Trust Investment Grade | BIOMARIN PHARMACEUTICAL INC | 09061GAL5 | DBT | 0.19% | $198K | May 29, 2026 | full (426 positions) |
| BMEZ BlackRock Health Sciences Term Trust Healthcare | BioMarin Pharmaceutical Inc | 09061G101 | EC | 0.17% | $1.8M | Jun 30, 2026 | full (170 positions) |
| BGT BlackRock Floating Rate Income Trust Senior Loans | BIOMARIN PHARMACEUTICAL INC | 09075UAD6 | LON | 0.14% | $593K | Jun 30, 2026 | full (476 positions) |
| FRA BlackRock Floating Rate Income Strategies Fund Senior Loans | BIOMARIN PHARMACEUTICAL INC | 09075UAD6 | LON | 0.14% | $722K | Jun 30, 2026 | full (463 positions) |
| DSU BlackRock Debt Strategies Fund Taxable Bonds | BIOMARIN PHARMACEUTICAL INC | 09075UAD6 | LON | 0.11% | $838K | Jun 30, 2026 | full (1,305 positions) |
| BLW BlackRock Ltd Duration Income Trust Taxable Bonds | BIOMARIN PHARMACEUTICAL INC | 09075UAD6 | LON | 0.11% | $583K | Jun 30, 2026 | full (1,781 positions) |
| VVR Invesco Senior Income Trust Senior Loans | BioMarin Pharmaceutical Inc. | 09075UAD6 | LON | 0.09% | $721K | May 31, 2026 | full (478 positions) |
| ISD PGIM High Yield Bond Fund High Yield | BIOMARIN PHARMACEUTICAL INC | 09061GAL5 | DBT | 0.09% | $405K | Jul 31, 2026 | full (803 positions) |
| HYT BlackRock Corporate High Yield Fund High Yield | BIOMARIN PHARMACEUTICAL | 09061GAL5 | DBT | 0.08% | $2.1M | Jun 30, 2026 | full (1,291 positions) |
| CPZ Calamos Long/Short Equity & Dynamic Income Trust U.S. Equity | BIOMARIN PHARMACEUTICAL | 09061GAL5 | DBT | 0.08% | $195K | Jul 31, 2026 | full (761 positions) |
| GHY PGIM Global High Yield Fund High Yield | BIOMARIN PHARMACEUTICAL INC | 09061GAL5 | DBT | 0.08% | $473K | Jul 31, 2026 | full (943 positions) |
| CHY Calamos Convertible & High Income Fund Convertible Securities | BIOMARIN PHARMACEUTICAL | 09061GAL5 | DBT | 0.07% | $1.1M | Jul 31, 2026 | full (601 positions) |
| JCE Nuveen Core Equity Alpha Fund U.S. Equity | BioMarin Pharmaceutical Inc | 09061G101 | EC | 0.07% | $204K | Jun 30, 2026 | full (144 positions) |
| CHI Calamos Convertible Opportunities & Income Fund Convertible Securities | BIOMARIN PHARMACEUTICAL | 09061GAL5 | DBT | 0.07% | $918K | Jul 31, 2026 | full (601 positions) |
| BLW BlackRock Ltd Duration Income Trust Taxable Bonds | BIOMARIN PHARMACEUTICAL | 09061GAL5 | DBT | 0.06% | $334K | Jun 30, 2026 | full (1,781 positions) |
| TY Tri-Continental Corp U.S. Equity | BioMarin Pharmaceutical Inc | 09061G101 | EC | 0.05% | $1.1M | Jun 30, 2026 | full (240 positions) |
| AWF AllianceBernstein Global High Income Fund High Yield | BIOMARIN PHARMACEUTICAL | 09061GAL5 | DBT | 0.05% | $491K | Jun 30, 2026 | full (1,236 positions) |
| JMM Nuveen Multi-Market Income Fund Taxable Bonds | BioMarin Pharmaceutical Inc | 09061GAL5 | DBT | 0.05% | $39.3K | Jun 30, 2026 | full (373 positions) |
| ETW Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund Covered Call / Option Income | BioMarin Pharmaceutical Inc | 09061G101 | EC | 0.05% | $548K | Jun 30, 2026 | full (258 positions) |
| PPT Franklin Premier Income Trust Taxable Bonds | BioMarin Pharmaceutical | 09075UAD6 | LON | 0.05% | $182K | Jul 31, 2026 | full (769 positions) |
| PIM Franklin Master Intermediate Income Trust Investment Grade | BioMarin Pharmaceutical | 09075UAD6 | LON | 0.04% | $85K | Jun 30, 2026 | full (734 positions) |
| BTZ BlackRock Credit Allocation Income Trust Taxable Bonds | BIOMARIN PHARMACEUTICAL | 09061GAL5 | DBT | 0.04% | $422K | Jun 30, 2026 | full (1,766 positions) |
| GAB Gabelli Equity Trust U.S. Equity | BIOMARIN PHARMACEUTICAL INC | 09061G101 | EC | 0.04% | $858K | Jun 30, 2026 | full (709 positions) |
| DSU BlackRock Debt Strategies Fund Taxable Bonds | BIOMARIN PHARMACEUTICAL | 09061GAL5 | DBT | 0.03% | $196K | Jun 30, 2026 | full (1,305 positions) |
| CSQ Calamos Strategic Total Return Fund Multi-Asset | BIOMARIN PHARMACEUTICAL | 09061GAL5 | DBT | 0.03% | $1.3M | Jul 31, 2026 | full (820 positions) |
| CCD Calamos Dynamic Convertible & Income Fund Convertible Securities | BIOMARIN PHARMACEUTICAL | 09061GAL5 | DBT | 0.03% | $244K | Jul 31, 2026 | full (596 positions) |
| CHW Calamos Global Dynamic Income Fund Taxable Bonds | BIOMARIN PHARMACEUTICAL | 09061GAL5 | DBT | 0.02% | $205K | Jul 31, 2026 | full (750 positions) |
| NMAI Nuveen Multi-Asset Income Fund Multi-Asset | BioMarin Pharmaceutical Inc | 09075UAD6 | LON | 0.02% | $152K | Jun 30, 2026 | full (1,176 positions) |
| BTZ BlackRock Credit Allocation Income Trust Taxable Bonds | BIOMARIN PHARMACEUTICAL INC | 09075UAD6 | LON | 0.01% | $103K | Jun 30, 2026 | full (1,766 positions) |
| GDV Gabelli Dividend & Income Trust U.S. Equity | BIOMARIN PHARMACEUTICAL INC | 09061G101 | EC | 0.00% | $132K | Jun 30, 2026 | full (729 positions) |
| VGI Virtus Global Multi-Sector Income Fund Multi-Asset | BIOMARIN PHARMACEUTICAL INC | 09061GAL5 | DBT | 0.00% | $4.9K | May 29, 2026 | full (758 positions) |
| ZTR Virtus Total Return Fund Multi-Asset | BIOMARIN PHARMACEUTICAL INC | 09061GAL5 | DBT | 0.00% | $9.9K | May 29, 2026 | full (796 positions) |
Matching position names
BIOMARIN PHARMACEUTICAL INC · 12BIOMARIN PHARMACEUTICAL · 11BioMarin Pharmaceutical Inc · 9Biomarin Pharmaceutical · 3BioMarin Pharmaceutical · 2BioMarin Pharmaceutical Inc. · 1
Historical holdings reports are not a real-time portfolio. Security-level matching (CUSIP/ISIN) distinguishes a company’s bonds, common shares, preferreds and derivatives; issuer-level matching groups them by name or ticker and is labelled as such. See the overlap tool to compare two portfolios.